Decision making and management of gliomas: Practical considerations

A. F. Hottinger, K. Homicsko, L. Negretti, B. Lhermitte, R. Stupp*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Over the last decade, diagnostic options and introduction of novel treatments have expanded the armamentarium in the management of malignant glioma. Combined chemoradiotherapy has become the standard of care in glioblastoma up to the age of 70 years, while treatment in elderly patients or with lower grade glioma is less well defined. Molecular markers define different disease subtypes and allow for adapted treatment selection. This review focuses on simple questions arising in the daily management of patients.

Original languageEnglish (US)
Pages (from-to)x33-x40
JournalAnnals of Oncology
Issue numberSUPPL. 10
StatePublished - Sep 2012


  • Anaplastic astrocytoma
  • Chemotherapy
  • Glioblastoma
  • IDH1
  • MGMT
  • Oligodendroglioma

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Decision making and management of gliomas: Practical considerations'. Together they form a unique fingerprint.

Cite this